Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
In the pancreas, GLP-1 receptor activation promotes insulin secretion and reduces glucagon secretion in a glucose-dependent manner
Diabetes, Metabolic Syndrome and Obesity
However, retatrutide is still investigational, tirzepatide has longer real-world experience, and side effects may be slightly more pronounced with retatrutide due to the triple-agonist mechanism
3 Additionally, they help reduce appetite and food intake, leading to weight loss
It is available as a weekly injection and is prescribed for individuals to assist with the management of their diabetes and weight management
Contact your insurance provider for coverage and copay details
US$ 24.91
US$ 25.85
US$ 28.04
